Contrast-induced nephropathy in patients with acute coronary syndrome with ST-segment elevation: risk factors and prognosis

Objective: to study the risk factors for acute renal injury, the dynamics of renal function and prognosis in patients with acute coronary syndrome with ST-segment elevation (STEACS) with contrast-induced nephropathy (CIN) after primary percutaneous coronary intervention (PCI).

Materials and methods. We studied 20 patients with STEACS, who developed СIN after PCI (follow-up group), and 98 patients with STEACS without СIN (comparison group). All patients were measured plasma creatinine level and glomerular filtration rate by the formula CKD-EPI before and 48 hours after PCI. CIN was detected with an increase in creatinine levels in the blood by more than 26.5 µmol / l from the baseline 48 hours after administration of radiopaque drug (RCP). Endpoints were evaluated at the hospital stage and within 12 months after PCI.

Results. CIN after PCI occurred in 16.9 % of patients with STEACS. Among patients with СIN, persons aged over 75 years (60 %), with diabetes mellitus (45 %), chronic kidney disease (75 %), postinfarction cardiosclerosis (50 %), chronic heart failure of functional class III–IV (80 %), developed acute heart failure T. Killip III–IV (90 %) were significantly more often observed. The left ventricular ejection fraction was lower in patients with СIN (p <0.05). The average increase in plasma creatinine 48 hours after PCI was higher in the follow-up group (p <0.05). In patients with СIN more often, than without СIN, three-vascular lesions of the coronary bed were detected (65 and 25.5 % respectively, p <0.001). The same trend was observed, when assessing the average number of coronary artery stenoses, the number of implanted stents and the volume of RCP used. Patients with СIN, than without СIN, were longer in hospital (12.1 ± 0.96 and 10.2 ± 1.11 days respectively, p <0.05) and more often needed re-hospitalization within 12 months after PCI (34 and 4.1 % respectively, p <0.05).

Summary. CIN in patients with STEACS after primary PCI was more likely to develop, if the following symptoms were present: age over 75 years, diabetes mellitus, chronic heart failure, post-infarction cardiosclerosis, chronic kidney disease, low ejection fraction of the left ventricle, initially high creatinine level, development of acute heart failure, trisovascular coronary lesion and multiple coronary stenting. The duration of hospital stay and the frequency of re-hospitalizations within a year after PCI significantly increased in patients in the CIN group.

1. Turenko O.I., Lebedeva A.Yu., Gordeev I.G., Volov N.A. The Problem of contrast-induced nephropathy in cardiology. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology 2011;89(30):78–86. (In Russ.).

2. Kalaeva V.V., Karetnikova V.N., Osokina A.V. et al. Risk factors of contrast-induced nephropathy in patients with myocardial infarction. Klinicheskaya meditsina = Clinical Medicine 2014;(9):39–45. (In Russ.).

3. KDIGO Clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2(1):6. DOI: 10.1038/kisup.2012.6.

4. Watabe H., Sato A., Hoshi T. et al. Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention. Int J Cardiol 2014;174(1):57–63. DOI: 10.1016/j.ijcard.2014.03.146.

5. Domaradskaya A.I. Contrast-induced nephropathy: risk factors. REJR 2011;1(4):27–32. (In Russ.).

6. Menzorov M.V., Shutov A.M., Serov V.A. et al. Acute kidney injury et patients with ST-elevated myocardial infarction. Nephrologiya = Nephrology 2012;16(1):40–4. (In Russ.).

7. Mehran R., Aymong E.D., Nikolsky E.A. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. Development and Initial Validation. J Am Coll Cardiol 2004;44(7):1393–9. DOI: 10.1016/j.jacc.2004.06.068.

8. Marenzi G., Assaneli E., Campodonico J. et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 2009;150(3):170–7. DOI: 10.7326/00034819-150-3-200902030-00006.

9. Vatutin N.T., Zinkevich M.I., Shevelek A.N. Prevalence of renal dysfunction in patients with acute coronary syndrome. Arkhiv vnutrenney meditsiny = Archive of internal medicine 2015;23(3):30–2. (In Russ.).

10. Shacham Y., Steinvil A., Arbel Y. Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity. J Nephrol 2016;29(2):169–74. DOI: 10.1007/s40620-015-0255-4.

11. Tepel M., Aspelin P., Lameire N. Contrast-induced nephropathy. A clinical and evidence-based approach. Circulation 2006;113(14):1799–806. DOI: 10.1161/CIRCULATIONAHA.105.595090.

12. Barrett B.J., Parfrey P.S. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 2006;354(4):1853–5. DOI: 10.1056/NEJMc060405.